SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-18-069403
Filing Date
2018-11-20
Accepted
2018-11-20 16:15:19
Documents
3
Group Members
DANIEL K. TURNER IIIMONTREUX EQUITY MANAGEMENT V, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a18-40521_1sc13da.htm SC 13D/A 92733
2 EX-99.1 a18-40521_1ex99d1.htm EX-99.1 9563
3 GRAPHIC g405211mmi001.gif GRAPHIC 2889
  Complete submission text file 0001104659-18-069403.txt   108123
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Subject) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-84019 | Film No.: 181195737
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
Montreux Equity Partners V, L.P. (Filed by) CIK: 0001548152 (see all company filings)

IRS No.: 455113281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A